Dahiroc, Rachel L.

HRN: 04-03-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2023
CEFTRIAXONE 1G (VIAL)
08/05/2023
08/11/2023
IV
2g
OD
Complicated UTI
Waiting Final Action 
08/05/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/05/2023
08/11/2023
IVT
2.25g
Q12hrs
Complicated UTI, AKI On Top Of CKD; DM Nephropathy; Electrolyte Imbalance
Waiting Final Action 
08/05/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/09/2023
08/11/2023
IV
2.25gm
Q8H
Complicated UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: